These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3396809)

  • 1. Glucocorticoids in muscular dystrophy: beneficial effects of dexamethasone on avian myopathy.
    Entrikin RK; Abresch RT; Bradford DP; Larson DB; Longley KJ; Wilson BW
    FASEB J; 1988 Aug; 2(11):2722-5. PubMed ID: 3396809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corticosteroid therapy in avian muscular dystrophy: evaluation by magnetic resonance relaxation times.
    Misra LK; Entrikin RK
    Exp Neurol; 1988 Nov; 102(2):217-20. PubMed ID: 3181360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of methimazole and dexamethasone in avian muscular dystrophy.
    Sabeur K; King DB; Entrikin RK
    Life Sci; 1993; 52(13):1149-59. PubMed ID: 8450709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of selective mineralocorticoid and glucocorticoid agonists in canine septic shock.
    Hicks CW; Sweeney DA; Danner RL; Eichacker PQ; Suffredini AF; Feng J; Sun J; Behrend EN; Solomon SB; Natanson C
    Crit Care Med; 2012 Jan; 40(1):199-207. PubMed ID: 21926575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Avian muscular dystrophy: functional and biochemical improvement with diphenylhydantoin.
    Entrikin RK; Swanson KL; Weidoff PM; Patterson GT; Wilson BW
    Science; 1977 Mar; 195(4281):873-5. PubMed ID: 841310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acetylcholinesterase in singly and multiply innervated muscles of normal and dystrophic chickens. II. Effects of denervation.
    Linhart RA; Wilson BW
    J Exp Zool; 1975 Aug; 193(2):191-200. PubMed ID: 1176901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myogenic defect in acetylcholinesterase regulation in muscular dystrophy of the chicken.
    Linkhart TA; Yee GW; Wilson BW
    Science; 1975 Feb; 187(4176):549-51. PubMed ID: 1114314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in genotypic expression, development, and the effects of chronic penicillamine treatment on the electrical properties of the posterior latissimus dorsi muscle in two lines of normal and dystrophic chickens.
    Warnick JE; Albuquerque EX
    Exp Neurol; 1979 Jan; 63(1):135-62. PubMed ID: 467541
    [No Abstract]   [Full Text] [Related]  

  • 9. Righting ability and skeletal muscle properties of phenytoin-treated dystrophic chickens.
    Entrikin RK; Patterson GT; Weidoff PM; Wilson BW
    Exp Neurol; 1978 Sep; 61(3):650-63. PubMed ID: 710572
    [No Abstract]   [Full Text] [Related]  

  • 10. Distribution of acetylcholinesterase activity in normal, dystrophic, and denervated muscles of the chicken.
    Patterson GT; Wilson BW
    Exp Neurol; 1976 Aug; 52(2):250-62. PubMed ID: 947765
    [No Abstract]   [Full Text] [Related]  

  • 11. Electrophysiologic differences between normal and dystrophic avian muscle.
    Howlett SE; Hoekman TB
    Exp Neurol; 1986 Nov; 94(2):416-25. PubMed ID: 3770130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retardation of symptoms of dystrophy in genetically dystrophic chickens by chemotherapy.
    Hudecki MS; Barnard EA
    Res Commun Chem Pathol Pharmacol; 1976 May; 14(1):167-76. PubMed ID: 935649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroidal involvement in the expression of avian muscular dystrophy.
    King DB; Entrikin RK
    Life Sci; 1991; 48(9):909-16. PubMed ID: 1997792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial effects of penicillamine treatment on hereditary avian muscular dystrophy.
    Chou T; Hill EJ; Bartle E; Woolley K; LeQuire V; Olson W; Roelofs R; Park JH
    J Clin Invest; 1975 Oct; 56(4):842-9. PubMed ID: 1159090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of myotonia in dystrophic chicken muscle by phenytoin.
    Entrikin RK; Bryant SH
    Am J Physiol; 1979 Sep; 237(3):C131-6. PubMed ID: 474742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of genetically dystrophic animals in chemotherapy trials and application of serotonin antagonists as antidystrophic drugs.
    Barnard EA; Barnard PJ
    Ann N Y Acad Sci; 1979; 317():374-99. PubMed ID: 289319
    [No Abstract]   [Full Text] [Related]  

  • 17. A preparation for studying dystrophic avian muscle and neuromuscular junctions.
    Gunther JS; Letinsky MS
    Muscle Nerve; 1982 Jan; 5(1):7-13. PubMed ID: 7057810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of motor nerve terminals in chickens with hereditary muscular dystrophy.
    Gunther JS; Letinsky MS
    Muscle Nerve; 1985 Sep; 8(7):568-75. PubMed ID: 2413354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Similar efficacy from specific and non-specific mineralocorticoid receptor antagonist treatment of muscular dystrophy mice.
    Lowe J; Floyd KT; Rastogi N; Schultz EJ; Chadwick JA; Swager SA; Zins JG; Kadakia FK; Smart S; Gomez-Sanchez EP; Gomez-Sanchez CE; Raman SV; Janssen PM; Rafael-Fortney JA
    J Neuromuscul Dis; 2016; 3(3):395-404. PubMed ID: 27822449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenytoin, methysergide, and penicillamine in hereditary muscular dystrophy of the chicken.
    Entrikin RK; Patterson GT; Wilson BW
    Exp Neurol; 1981 Apr; 72(1):82-90. PubMed ID: 7202629
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.